Author:
Chincarini Andrea,Sensi Francesco,Rei Luca,Gemme Gianluca,Squarcia Sandro,Longo Renata,Brun Francesco,Tangaro Sabina,Bellotti Roberto,Amoroso Nicola,Bocchetta Martina,Redolfi Alberto,Bosco Paolo,Boccardi Marina,Frisoni Giovanni B.,Nobili Flavio
Funder
Istituto Nazionale di Fisica Nucleare (INFN), Italy
INFN
Università degli Studi Di Genova
Alzheimer's Disease Neuroimaging Initiative
National Institutes of Health
DOD ADNI
Department of Defense
National Institute on Aging
National Institute of Biomedical Imaging and Bioengineering
AbbVie
Alzheimer's Association
Alzheimer's Drug Discovery Foundation
Araclon Biotech
BioClinica, Inc.
Biogen
Bristol-Myers Squibb Company
CereSpir, Inc.
Eisai Inc.
Elan Pharmaceuticals, Inc.
Eli Lilly and Company
EuroImmun
F. Hoffmann-La Roche Ltd
Genentech, Inc.
Fujirebio
GE Healthcare
IXICO Ltd.
Janssen Alzheimer Immunotherapy Research & Development, LLC.
Johnson & Johnson Pharmaceutical Research & Development LLC.
Lumosity
Lundbeck
Merck & Co., Inc.
MesoScale Diagnostics, LLC.
NeuroRx Research
Neurotrack Technologies
Novartis Pharmaceuticals Corporation
Pfizer Inc.
Piramal Imaging
Servier
Takeda Pharmaceutical Company
Transition Therapeutics
Canadian Institutes of Health Research
Subject
Cognitive Neuroscience,Neurology